Redeye: Hexatronic Q2 - Strong Q2 – Unchanged Outlook
Redeye will likely increase its Base Case and forecasts following a strong Q2 report, with solid improvements in sales, gross, and EBITA margins q/q. On the other hand, the FTTH outlook remains unchanged, which might disappoint some investors considering the optimism among many US peers.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/